Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

‘Microsoft indefinitely delays employees’ return to its offices’ -Engadget Report

https://www.engadget.com/microsoft-office-return-delay-indefinite-covid-19-delta-191909008.html?src=rss

byBenzinga Newsdesk

September 9, 2021

1 minute read

https://www.engadget.com/microsoft-office-return-delay-indefinite-covid-19-delta-191909008.html?src=rss

Michael Weiner Succeeds Edward Fitzpatrick As Genpact CFO

By Anusuya Lahiri

July 21, 6:50 AM

Genpact Ltd (NYSE:G) appointed Michael Weiner as the CFO, effective Aug. 10. Weiner succeeds Edward Fitzpatrick, who has served as Genpact’s…

News

Popular Science Teams Up With hOmeLabs To Launch Co-Branded Air Purifier; No Terms Disclosed

By Benzinga Newsdesk

August 18, 4:23 PM

NEW YORK, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Popular Science and hOmeLabs are proud to announce the launch of their newly co-branded air purifier. This is the first co-branded product from the partnership between Recurrent and Aterian, which was announced in December 2021.

ATER

Citigroup Maintains Buy on DocuSign, Lowers Price Target to $90

By Benzinga Newsdesk

June 10, 8:35 AM

Citigroup analyst Tyler Radke maintains DocuSign (NASDAQ:DOCU) with a Buy and lowers the price target from $114 to $90.

DOCU

Alpha Healthcare Acquisition Announces Shareholder Approval Of Business Combination With Humacyte

By Benzinga Newsdesk

August 24, 1:00 PM

Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC) ("AHAC"), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination with

AHAC

‘Microsoft indefinitely delays employees’ return to its offices’ -Engadget Report

Related Posts

Michael Weiner Succeeds Edward Fitzpatrick As Genpact CFO

Popular Science Teams Up With hOmeLabs To Launch Co-Branded Air Purifier; No Terms Disclosed

Citigroup Maintains Buy on DocuSign, Lowers Price Target to $90

Alpha Healthcare Acquisition Announces Shareholder Approval Of Business Combination With Humacyte